NASDAQ$BIOX
Bioceres Crop Solutions Corp · Q3 2026 earnings
Q3 2026 earnings · · Before market open · Investor relations
Briefing
Bioceres fiscal Q3 2026: revenue falls 23% to $39.4M as Seeds transition and Crop Protection softness weigh
Bioceres Crop Solutions reported fiscal third quarter 2026 results for the three months ended March 31, 2026. Total revenue from continuing operations was $39.4 million, down 23% from $51.1 million in Q3 2025, reflecting softer Crop Protection demand, competitive pressures, and the ongoing transition in Seeds toward a more asset-light model. Crop Protection revenue fell 18% to $24.6 million, Seed and Integrated Products revenue declined 71% to $3.2 million, while Crop Nutrition grew 15% to $11.6 million on microbeaded fertilizer demand. Gross profit was $12.7 million with a 32% margin versus 35% a year ago, impacted by product mix and a non-recurring inoculants obsolescence adjustment. The company reported a net loss of $10.0 million and adjusted EBITDA of $(0.6) million, compared with net income of $2.3 million and adjusted EBITDA of $9.1 million in Q3 2025. SG&A fell 16% to $16.1 million as cost-management initiatives continued amid Pro Farm litigation and liability-management efforts.
- Total revenue fell 23% to $39.4M; Crop Protection down 18% to $24.6M and Seeds down 71% to $3.2M, partly offset by Crop Nutrition up 15% to $11.6M.
- Gross profit was $12.7M with 32% margin, down from $18.1M and 35% in Q3 2025, including a non-recurring inoculants obsolescence charge.
- Net loss was $10.0M versus net income of $2.3M; adjusted EBITDA was $(0.6)M compared with $9.1M a year ago.
- SG&A declined 16% to $16.1M through organizational streamlining and cost management across continuing operations.
- Management is advancing liability-management initiatives and a strategic review while navigating Pro Farm foreclosure litigation.
Headline financials
Revenue & EPS history
Bioceres · Revenue · Quarterly
$39.4M
Revenue by segment
Bioceres · $39.4M total across 3 segments · Q3 2026
- Crop protection$24.6M-42.3%62.4%
- Crop nutrition$11.6M+49.2%29.4%
- Seed and integrated products$3.2M-68.5%8.1%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2026
-0.9%
Avg return
Earnings day
-0.0%
Avg return
5 days after
-3.9%
Avg return
30 days after
41%
12 / 29 earnings
Positive
+12.6%
Q3 2023
Best reaction
-14.4%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -5.6% | -20.1% | -20.7% | |
| Q2 2026 | -9.2% | -12.8% | -16.0% | |
| Q3 2025 | -5.2% | -0.4% | -2.4% | |
| Q4 2024 | -14.4% | -15.2% | -26.2% | |
| Q3 2024 | -7.0% | -10.8% | -16.2% | |
| Q2 2024 | +4.0% | +3.1% | +1.5% | |
| Q1 2024 | +6.7% | +13.6% | +28.0% | |
| Q4 2023 | -2.3% | -0.4% | -4.1% | |
| Q3 2023 | +12.6% | +20.3% | +22.5% | |
| Q2 2023 | -8.4% | -2.4% | -6.8% | |
| Q1 2023 | +5.5% | +1.9% | -12.7% | |
| Q4 2022 | -2.9% | -2.9% | -10.3% | |
| Q3 2022 | +5.4% | +12.8% | +9.7% | |
| Q2 2022 | +1.8% | +1.4% | +19.1% | |
| Q1 2022 | +8.2% | +15.9% | +9.0% | |
| Q4 2021 | -6.5% | -8.2% | -2.2% | |
| Q3 2021 | +3.0% | +5.6% | -5.3% | |
| Q2 2021 | -1.9% | -1.7% | -7.5% | |
| Q1 2021 | -0.2% | -0.7% | -7.2% | |
| Q4 2020 | +4.8% | +7.0% | +17.9% | |
| Q3 2020 | -6.6% | -1.9% | -4.0% | |
| Q2 2020 | +4.7% | +13.5% | -12.5% | |
| Q1 2020 | -5.5% | -0.7% | -7.7% | |
| Q4 2019 | +0.0% | -7.4% | -6.6% | |
| Q3 2019 | -8.7% | -11.1% | -7.2% | |
| Q2 2019 | +0.2% | +0.2% | -47.4% | |
| Q1 2019 | +0.0% | +0.0% | +2.6% | |
| Q4 2018 | +0.2% | +0.0% | +0.2% | |
| Q3 2018 | +0.0% | +0.7% | +0.5% | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro